Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML

Journal:
Cell Stem Cell
Published:
Affiliations:
17
Authors:
30
Institutions Authors Share
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany
6.000000
0.20
DKFZ-ZMBH Alliance, Germany
4.416667
0.15
Heidelberg Institute for Stem Cell Technologies and Experimental Medicine (HI-STEM gGmbH), Germany
4.416667
0.15
German Consortium of Translational Cancer Research (DKTK), Germany
2.166667
0.07
Institute for Molecular Medicine Finland (FIMM), Finland
2.000000
0.07
Heidelberg University (Uni Heidelberg), Germany
1.500000
0.05
Max Planck Institute of Immunobiology and Epigenetics (MPI-IE), Germany
1.500000
0.05
Hannover Medical School (MHH), Germany
1.500000
0.05
German Red Cross Blood Donor Service Baden-Wuerttemberg-Hessen, Germany
1.000000
0.03
University Hospital Frankfurt, GU, Germany
1.000000
0.03
University Hospital Carl Gustav Carus Dresden, TU Dresden, Germany
1.000000
0.03
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA)
1.000000
0.03
National Center for Tumor Diseases (NCT) Heidelberg, Germany
0.750000
0.03
University Hospital in Halle (Saale) (UKH), MLU, Germany
0.500000
0.02
MV-Zentrum für Onkologie und Hämatologie, Germany
0.500000
0.02
Swiss Federal Institute of Technology Zurich (ETH Zurich), Switzerland
0.500000
0.02
Molecular Medicine Partnership Unit (MMPU), Germany
0.250000
0.01